Korlym and Clonidine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Korlym (mifepristone) and Clonidine (clonidine). Common drug interactions include abdominal discomfort among females and pain in extremity among males.

The phase IV clinical study analyzes what interactions people have when they take Korlym and Clonidine. It is created by eHealthMe based on reports of 99 people who take the same drugs from the FDA, and is updated regularly.

What is Korlym?

Korlym has active ingredients of mifepristone. eHealthMe is studying from 3,078 Korlym users. Check the latest studies of Korlym.

What is Clonidine?

Clonidine has active ingredients of clonidine. It is often used in high blood pressure. eHealthMe is studying from 65,644 Clonidine users. Check the latest studies of Clonidine.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 21, 2026

99 people who take Korlym and Clonidine together, and have interactions are studied.

Korlym and Clonidine drug interactions.

What are the common drug interactions of Korlym and Clonidine, by gender? *:

female:

  1. Abdominal discomfort
  2. Cardiac flutter (abnormal heart rhythm)
  3. Blood creatinine increased
  4. Depressed mood
  5. Seasonal allergy (allergic condition due to certain season)
  6. Tremor (trembling or shaking movements in one or more parts of your body)
  7. Chronic kidney disease
  8. Dyspnoea (difficult or laboured respiration)
  9. Mean cell volume increased (more than normal average red blood cell volume)
  10. Protein urine present

male:

  1. Pain in extremity
  2. Fatigue (feeling of tiredness)
  3. Cardiac flutter (abnormal heart rhythm)
  4. Asthenia (weakness)
  5. Decreased appetite
  6. Oedema (fluid collection in tissue)
  7. Peripheral arterial occlusive disease (reproducible ischemic muscle pain)
  8. Constipation
  9. Arteriosclerosis (thickening and hardening of arteries)
  10. Dehydration (dryness resulting from the removal of water)

What are the common drug interactions of Korlym and Clonidine, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Amenorrhoea (absence of a menstrual period in a woman of reproductive age)
  2. Dysmenorrhoea (painful menstruation)
  3. Fatigue (feeling of tiredness)
  4. Vaginal haemorrhage (vaginal bleeding)
  5. Blood pressure decreased
  6. Cardiac flutter (abnormal heart rhythm)
  7. Constipation
  8. Cough
  9. Decreased appetite
  10. Diarrhoea

50-59:

  1. Rash
  2. Blood magnesium decreased
  3. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
  4. Erythema (redness of the skin)
  5. Pruritus (severe itching of the skin)
  6. Skin burning sensation
  7. Fatigue (feeling of tiredness)
  8. Feeling of body temperature change
  9. Weight decreased
  10. Asthenia (weakness)

60+:

  1. Nausea (feeling of having an urge to vomit)
  2. Blood glucose decreased
  3. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  4. Bursa disorder
  5. Cardiac failure congestive
  6. Contusion (a type of hematoma of tissue in which capillaries)
  7. Haematochezia (passage of stools containing blood)
  8. International normalised ratio increased
  9. Oropharyngeal pain
  10. Red blood cell count decreased

What are the existing conditions these people have? *

  1. Cushing's Syndrome (obesity, a rounded face, increased fat): 87 people, 87.88%
  2. Pituitary-Dependent Cushing's Syndrome (pituitary dependent hypercortisolism): 11 people, 11.11%
  3. Type 2 Diabetes: 5 people, 5.05%

* Approximation only. Some reports may have incomplete information.

Do you take Korlym and Clonidine?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Korlym and Clonidine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Korlym:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Clonidine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Korlym and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Clonidine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on mifepristone and clonidine (the active ingredients of Korlym and Clonidine, respectively), and Korlym and Clonidine (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: